Opioid Free Anesthesia in Total Hip Arthroplasty (OFATHA)

  • End date
    Aug 4, 2023
  • participants needed
  • sponsor
    CMC Ambroise Paré
Updated on 26 March 2022


Total hip arthroplasty (THA) is one of the most common orthopedic surgical procedure and is associated with severe pain in the immediate postoperative period, thus limiting early recovery.

Postoperative pain management in THA requires multimodal analgesia, combining drugs and injection of a local anesthetic (LA). But, the best anesthesia strategy to provide optimal postoperative analgesia in THA remains controversial. Opioid free anesthesia could limit the episodes of hyperalgesia as well as tolerance and addiction to opioids.

The hypothesis of this study is that an opioid free anesthesia using dexmedetomidine could improve analgesia after THA.

The main objective of this monocenter, prospective, randomized, triple-blind, controlled trial is to assess the interest of opioid free anesthesia using dexmedetomidine on morphine consumption after THA.


In the pre-anaesthesia room, after the implementation of classical monitoring and a peripheral venous catheter, all patients will receive an antibioprophylaxis according to SFAR (French Society of Anesthesia & Intensive Care Medecine) recommendations and injection of 10 mg of IV dexamethasone.

The patients will be then randomized in 2 groups:

Control group:

  • Pre-operative normal saline infusion 100 ml over 30 minutes
  • Injection of sufentanil 10 µg in normal saline 2 ml on induction of anesthesia

If needed after incision :

  • Per-operative normal saline infusion 100 ml
  • Per-operative injection of sufentanil 5 µg in normal saline 1 ml

OFA group (experimental group):

  • Pre-operative dexmedetomidine infusion 1 µg/kg in normal saline 100 ml over 30 minutes
  • Injection of normal saline 2 ml on induction of anesthesia

If needed after incision :

  • Per-operative dexmedetomidine infusion 0.4 µg/kg in normal saline 100 ml
  • Per-operative injection of normal saline 1 ml

In the operating room, general anesthesia will be induced by intravenous ketamine (0.4 mg/kg) + propofol (3 mg/kg) +/- cisatracurium (0.1 mg/kg) for the introduction of laryngeal mask airway. Anesthesia will be maintained with propofol.

Postoperative analgesia protocol :

  • Multimodal analgesia will be instituted during surgery by the administration of paracetamol (1 g), nefopam (20 mg) and ketoprofen (100 mg) and the infiltration of the surgical wound with 100 ml of ropivacaine 0.2%.
  • In post-anesthesia care unit (PACU): oxycodone titration if NRS (pain score) >3 according to the centre's usual care.
  • In ward and at home: systematic per os analgesia with paracetamol (1 g, 4 times a day) and ibuprofen (400 mg, 3 times a day); oxycodone (10 mg, lockout interval: 4 h) if NRS (pain score) >3.

Condition Primary Total Hip Arthroplasty
Treatment Dexmedetomidine, Sufentanil
Clinical Study IdentifierNCT05072704
SponsorCMC Ambroise Paré
Last Modified on26 March 2022


Yes No Not Sure

Inclusion Criteria

years and older
Undergoing outpatient primary total hip arthroplasty under general anesthesia with laryngeal mask
Consent for participation
Affiliation to a social security system

Exclusion Criteria

Heart rate < 60 bpm
Chronic pain syndrome requiring preoperative morphine use (class 3)
Contraindication for: paracetamol, ketoprofen, nefopam, oxycodone, propofol, ketamine, cisatracurium, sufentanyl, ropivacaine
Contraindication for dexmedetomidine: hypersensitivity to the active substance or to any of the excipients, advanced cardiac block (grade 2 or 3) unless paced ; uncontrolled hypotension ; acute cerebrovascular conditions
Contraindication to laryngeal mask : old insulin-dependent diabetes, gastro-oesophageal reflux, morbid obesity (defined by BMI > 35)
Pregnant or breastfeeding women
Women of child bearing potential without contraception (any contraceptive method used regularly and appropriately with a low failure rate: <1% per year)
A mental or linguistic inability to understand the study
Patient under protection of the adults (guardianship, curators or safeguard of justice)
Patient included or planning to be included in another clinical trial relating to medications
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note